These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 24692093

  • 1. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
    Giglio J, Dematteis S, Fernández S, Cerecetto H, Rey A.
    J Labelled Comp Radiopharm; 2014 May 30; 57(6):403-9. PubMed ID: 24692093
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, in vitro and in vivo characterization of novel 99mTc-'4+1'-labeled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
    Giglio J, Fernández S, Pietzsch HJ, Dematteis S, Moreno M, Pacheco JP, Cerecetto H, Rey A.
    Nucl Med Biol; 2012 Jul 30; 39(5):679-86. PubMed ID: 22534030
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
    Su H, Chu T.
    Bioorg Med Chem Lett; 2022 Mar 15; 60():128583. PubMed ID: 35085720
    [Abstract] [Full Text] [Related]

  • 4. Influence of ligand denticity on the properties of novel ⁹⁹mTc(I)-carbonyl complexes. Application to the development of radiopharmaceuticals for imaging hypoxic tissue.
    Fernández S, Giglio J, Rey AM, Cerecetto H.
    Bioorg Med Chem; 2012 Jul 01; 20(13):4040-8. PubMed ID: 22658538
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological characterisation of novel dithiocarbamate containing 5-nitroimidazole (99m)Tc-complexes as potential agents for targeting hypoxia.
    Giglio J, Fernández S, Rey A, Cerecetto H.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):394-7. PubMed ID: 21087863
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, in vitro and in vivo characterization of two novel 68Ga-labelled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
    Fernández S, Dematteis S, Giglio J, Cerecetto H, Rey A.
    Nucl Med Biol; 2013 Feb 01; 40(2):273-9. PubMed ID: 23218939
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of in vivo distribution through chelator: Synthesis and evaluation of a 2-nitroimidazole-dipicolylamine-(99m)Tc(CO)3 complex for detecting tumor hypoxia.
    Mallia MB, Mittal S, Sarma HD, Banerjee S.
    Bioorg Med Chem Lett; 2016 Jan 01; 26(1):46-50. PubMed ID: 26615889
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and Biological Evaluation of a New Nitroimidazole-99mTc-Complex for Imaging of Hypoxia in Mice Model.
    Zhang Q, Zhang Q, Guan Y, Liu S, Chen Q, Li X.
    Med Sci Monit; 2016 Oct 18; 22():3778-3791. PubMed ID: 27752036
    [Abstract] [Full Text] [Related]

  • 11. 99mTc labelled complexes with secnidazole xanthate: Synthesis and evaluation as potential radiotracers to target tumor hypoxia.
    Lin X, Ruan Q, Zhang X, Duan X, Teng Y, Zhang J.
    Appl Radiat Isot; 2018 Oct 18; 140():289-293. PubMed ID: 30092554
    [Abstract] [Full Text] [Related]

  • 12. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.
    Schibli R, La Bella R, Alberto R, Garcia-Garayoa E, Ortner K, Abram U, Schubiger PA.
    Bioconjug Chem; 2000 Oct 18; 11(3):345-51. PubMed ID: 10821650
    [Abstract] [Full Text] [Related]

  • 13. Preparation and bioevaluation of a novel 99mTc-labelled propylene amine oxime (PnAO) containing two 4-methyl-2-nitroimidazole groups as a promising tumor hypoxia imaging agent.
    Li S, Chu T.
    Bioorg Med Chem Lett; 2024 Jul 01; 106():129773. PubMed ID: 38677561
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of [99mTcN]2+ core and [99mTcO]3+ core labeled complexes with 4-nitroimidazole xanthate derivative for tumor hypoxia imaging.
    Ruan Q, Zhang X, Gan Q, Fang S, Zhang J.
    Bioorg Med Chem Lett; 2020 Nov 15; 30(22):127582. PubMed ID: 33002601
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
    Zhang Q, Huang H, Chu T.
    J Labelled Comp Radiopharm; 2016 Jan 15; 59(1):14-23. PubMed ID: 26690916
    [Abstract] [Full Text] [Related]

  • 16. [Preparation of (99m)Tc-EDTA-MN and Its Bioimaging in Mouse].
    Qi Y, Li G, Chi X, Du L, Huang K, Zhang H, Huang B.
    Zhongguo Fei Ai Za Zhi; 2015 Jul 15; 18(7):422-6. PubMed ID: 26182867
    [Abstract] [Full Text] [Related]

  • 17. Improving tumor/muscle and tumor/blood ratios of 99mTc-labeled nitroimidazole propylene amine oxime (PnAO) complexes with ethylene glycol linkers.
    Li S, Chu T.
    Bioorg Med Chem Lett; 2023 Feb 15; 82():129154. PubMed ID: 36736496
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological evaluation of novel (99m)Tc-labelled bisphosphonates as superior bone imaging agents.
    Qiu L, Cheng W, Lin J, Luo S, Xue L, Pan J.
    Molecules; 2011 Jul 25; 16(8):6165-78. PubMed ID: 21788926
    [Abstract] [Full Text] [Related]

  • 19. A thiourea-bridged 99mTc(CO)3-dipicolylamine-2-nitroimidazole complex for targeting tumor hypoxia: Utilizing metabolizable thiourea-bridge to improve pharmacokinetics.
    Mittal S, Kumar C, Jha L, Mallia MB.
    Drug Dev Res; 2024 Sep 25; 85(6):e22258. PubMed ID: 39253992
    [Abstract] [Full Text] [Related]

  • 20. Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia.
    Li Z, Lin X, Zhang J, Wang X, Jin Z, Zhang W, Zhang Y.
    Nucl Med Biol; 2016 Feb 25; 43(2):165-70. PubMed ID: 26872441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.